He Took a Psychedelic to Cure His Addiction. It Was His Last Trip
Safety (cardiac & more) Journalism high
⚠ Contains fatality data
AI-extracted · unverified · confirm at source
Rolling Stone investigation: 49-year-old American died at Beond clinic Cancún. Documents industry safety failures, inadequate screening, regulatory gaps in unregulated ibogaine treatment settings.
Dosing: undisclosed (ibogaine flood dose + booster) (oral)
Sample size: 1
Contraindications: Concurrent buprenorphine use (Suboxone) — flagged in source as particularly dangerous with long-acting opiates, Concurrent benzodiazepine use (Valium), Active polydrug use at admission (fentanyl, cocaine, buprenorphine, benzodiazepine), Recent fentanyl use